Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China flag China · Delayed Price · Currency is CNY
42.10
+0.22 (0.53%)
Nov 17, 2026, 3:00 PM CST

SHA:688050 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,7821,4741,404947.42575.86431.2
Other Revenue
8.388.386.43.753.641.87
1,7911,4831,410951.18579.5433.07
Revenue Growth
21.07%5.16%48.24%64.14%33.81%58.61%
Cost of Revenue
696.17556.55479.83230.0488.3568.08
Gross Profit
1,095926.15930.19721.14491.15364.99
Selling, General & Admin
600.47448.26370.67296.94178.57142.27
Research & Development
108.8794.67106.4291.9563.951.91
Other Operating Expenses
13.588.554.7514.988.697.17
Operating Expenses
731.74561.22492.69412.99259.52207.1
Operating Income
362.84364.93437.5308.16231.62157.89
Interest Expense
-30.85-22.98-20.73-9.81-2.02-0.74
Interest & Investment Income
6.37.684.1719.9821.9725.56
Currency Exchange Gain (Loss)
0.80.8-0.460.62-0.23-0.92
Other Non Operating Income (Expenses)
-8.65-1.69-2.080.03-0.52-0.15
EBT Excluding Unusual Items
330.44348.73418.39318.97250.81181.65
Impairment of Goodwill
-57.36-57.36----
Gain (Loss) on Sale of Investments
-0.220.2-0.69-1.841.490.2
Gain (Loss) on Sale of Assets
0.17-0.09-0.080.110.010.02
Asset Writedown
-12.23-14.8-1.98---
Other Unusual Items
15.5312.5815.4510.4311.775.9
Pretax Income
276.33289.26431.1327.67264.08187.77
Income Tax Expense
46.648.6744.0241.6236.8520.01
Earnings From Continuing Operations
229.73240.59387.08286.05227.23167.75
Minority Interest in Earnings
13.9327.581.3217.935.463.59
Net Income
243.66268.17388.4303.98232.69171.34
Net Income to Common
243.66268.17388.4303.98232.69171.34
Net Income Growth
-32.50%-30.96%27.77%30.63%35.80%77.45%
Shares Outstanding (Basic)
193192189189190189
Shares Outstanding (Diluted)
193192189190190189
Shares Change
0.55%1.10%-0.27%0.25%0.17%17.57%
EPS (Basic)
1.261.402.051.611.230.91
EPS (Diluted)
1.261.402.051.601.230.91
EPS Growth
-32.87%-31.71%28.13%30.31%35.58%50.93%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
144.79246.0118.27-157.72-20.9-91.92
Free Cash Flow Per Share
0.751.280.10-0.83-0.11-0.49
Dividend Per Share
0.3200.3200.3500.2720.2830.206
Dividend Growth
-8.57%-8.57%28.58%-3.92%37.79%32.13%
Gross Margin
61.12%62.46%65.97%75.82%84.75%84.28%
Operating Margin
20.26%24.61%31.03%32.40%39.97%36.46%
Profit Margin
13.61%18.09%27.55%31.96%40.15%39.56%
Free Cash Flow Margin
8.09%16.59%1.30%-16.58%-3.61%-21.22%
EBITDA
545.61524.42565.96380.52271.42188.07
EBITDA Margin
30.47%35.37%40.14%40.01%46.84%43.43%
D&A For EBITDA
182.76159.49128.4672.3639.7930.18
EBIT
362.84364.93437.5308.16231.62157.89
EBIT Margin
20.26%24.61%31.03%32.40%39.97%36.46%
Effective Tax Rate
16.86%16.83%10.21%12.70%13.95%10.66%
Revenue as Reported
1,7911,4831,410951.18579.5433.07